Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States

被引:79
作者
Theuer, CP
Wagner, JL
Taylor, TH
Brewster, WR
Tran, D
McLaren, CE
Anton-Culver, H
机构
[1] Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Surg, Irvine, CA 92697 USA
[3] Long Beach Vet Adm Med Ctr, Long Beach, CA USA
[4] Univ Calif Irvine, Dept Obstet & Gynecol, Div Epidemiol, Irvine, CA 92697 USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92697 USA
[6] Congress Budget Off, Washington, DC USA
关键词
D O I
10.1053/gast.2001.22535
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background&Aims: Colorectal cancer screening beginning at age 50 is recommended for all Americans considered at "average" risk for the development of colorectal cancer. Methods: We used 1988-1995 California Cancer Registry data to compare the cost-effectiveness of two 35-year colorectal cancer screening interventions among Asians, blacks, Latinos, and Whites. Results: Average annual age-specific colorectal cancer incidence rates were highest in blacks and lowest in Latinos. Screening beginning at age 50 was most cost-effective in blacks and least cost-effective in Latinos (measured as dollars spent per year of life saved), using annual fecal occult blood testing (FOBT) combined with flexible sigmoidoscopy every 5 years and using colonoscopy every 10 years. A 35-year screening program beginning in blacks at age 42, whites at age 44, or Asians at age 46 was more cost-effective than screening Latinos beginning at age 50, Conclusions: Colorectal cancer screening programs beginning at age 50, using either FOBT and flexible sigmoidoscopy or colonoscopy in each racial or ethnic group, are within the $40,000-$60,000 per year of life saved upper cost limit considered acceptable for preventive strategies. Screening is most cost-effective in blacks because of high age-specific colorectal cancer incidence rates.
引用
收藏
页码:848 / 856
页数:9
相关论文
共 45 条
[1]  
[Anonymous], 1992, P229 SAS I INC
[2]   PREVENTION OF COLORECTAL-CANCER BY ONCE-ONLY SIGMOIDOSCOPY [J].
ATKIN, WS ;
CUZICK, J ;
NORTHOVER, JMA ;
WHYNES, DK .
LANCET, 1993, 341 (8847) :736-740
[3]   Screening colonoscopy: The cost of common sense [J].
Bhattacharya, I ;
Sack, EM .
LANCET, 1996, 347 (9017) :1744-1745
[4]   American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997 [J].
Byers, T ;
Levin, B ;
Rothenberger, D ;
Dodd, GD ;
Smith, RA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (03) :154-&
[5]  
*CA TUM REG, 1986, CANC REP CAL, V1
[6]  
*CDCP, 1998, US DEC LIF TABL 1989, V2
[7]  
Chen VW, 1997, CANCER EPIDEM BIOMAR, V6, P1087
[8]   PREVALENCE OF DISTAL COLONIC NEOPLASIA ASSOCIATED WITH PROXIMAL COLON CANCERS [J].
DINNING, JP ;
HIXSON, LJ ;
CLARK, LC .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (08) :853-856
[9]  
EDDY D, 1980, CA CANC J CLIN, V30, P3
[10]   FLEXIBLE SIGMOIDOSCOPY MAY BE INEFFECTIVE FOR SECONDARY PREVENTION OF COLORECTAL-CANCER IN ASYMPTOMATIC, AVERAGE-RISK MEN [J].
FOUTCH, PG ;
MAI, H ;
PARDY, K ;
DISARIO, JA ;
MANNE, RK ;
KERR, D .
DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (07) :924-928